Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $3.8 million.

  • Inspire Medical Systems' Depreciation & Amortization (CF) rose 5423.73% to $3.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $14.0 million, marking a year-over-year increase of 11308.4%. This contributed to the annual value of $14.0 million for FY2025, which is 11308.4% up from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Depreciation & Amortization (CF) is $3.8 million, which was up 5423.73% from $3.7 million recorded in Q3 2025.
  • In the past 5 years, Inspire Medical Systems' Depreciation & Amortization (CF) ranged from a high of $3.8 million in Q4 2025 and a low of $234000.0 during Q1 2021
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $718000.0 (2023), whereas its average is $1.3 million.
  • In the last 5 years, Inspire Medical Systems' Depreciation & Amortization (CF) skyrocketed by 2513.37% in 2021 and then surged by 26281.29% in 2025.
  • Inspire Medical Systems' Depreciation & Amortization (CF) (Quarter) stood at $344000.0 in 2021, then skyrocketed by 65.41% to $569000.0 in 2022, then surged by 43.59% to $817000.0 in 2023, then surged by 203.3% to $2.5 million in 2024, then soared by 54.24% to $3.8 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $3.8 million for Q4 2025, versus $3.7 million for Q3 2025 and $3.4 million for Q2 2025.